To validate the observations of circulating methylated SRCIN1 in breast cancer patients, as identified by a genome-wide methylation array in plasma, we conducted a methylation array analysis on five paired breast cancer tissue samples. The gene discussed is SRCIN1; the disease is breast carcinoma.